Home | Multiple Myeloma Hub

Online resource for healthcare professionals, providing information, news & support relating to multiple myeloma

Source: multiplemyelomahub.com

Categories: Onc News and Journals, General Medicine News

Tags: RRMM,MultipleMyeloma,mmsm,MedNews,MedEd

Tweets with this article

Multiple Myeloma Hub

DREAMM-8 study published in @NEJM found among lenalidomide-exposed patients with #RRMM, BPd conferred a much greater benefit than PVd with respect to PFS, as well as deeper, more durable responses 📝 More news: https://t.co/mlBz7MV4Hy #MultipleMyeloma #mmsm #MedNews #MedEd https://t.co/fnqxeAfQA7

Oncology Policy Summits

Register now! Measuring and Addressing Health-Related Social Needs in Cancer Tuesday, September 12, 2023 National Press Club, Washington, D.C. | Virtual attendance also available Navigating…

National Comprehensive Cancer Network (NCCN) April 25, 2025

April 2025 | Blood Cancers Today

This issue of Blood Cancers Today includes a feature on how government funding can impact hematologic oncology, an editor’s letter by Mehdi H. Hamadani, MD,…

Blood Cancers Today April 25, 2025

Perioperative Durvalumab-Based Regimen Receives European Approval for Resectable NSCLC

Durvalumab has received perioperative approval in the European Union in patients with resectable non–small cell lung cancer based on data from AEGEAN.

OncLive.com April 25, 2025

CELMoDs for the treatment of MM: Latest clinical trial data

Here, we summarize the latest clinical trial data from studies evaluating the novel CELMoDs, iberdomide and mezigdomide, for the treatment of multiple myeloma.

Multiple Myeloma Hub April 25, 2025

Adjuvant/neoadjuvant treatment of cutaneous SCC

Vishal Patel, MD, FAAD, FACMS, George Washington University (GW), Washington, DC, comments on the shifting paradigm in treating locally advanced cutaneous squamous cell carcinoma (SCC),…

VJ Oncology April 25, 2025

HCT & CAR T Access: Unseen Barriers & Inequities in Care

Hannah Abrams, MD, discusses the background behind research into nonmedical barriers to cell transplant and CAR T therapy.

Targeted Oncology April 25, 2025

Let’s fight cancer together

Join MD Anderson to help dramatically accelerate the pace of converting scientific discoveries into clinical advances that reduce the devastating effects of cancer.

MD Anderson Cancer Center April 24, 2025

SurgOnc Today® – Society of Surgical Oncology

SurgOnc Today® is an educational podcast for cancer surgeons from the Society of Surgical Oncology. Each episode features conversations with individuals who are experts within their…

Society of Surgical Oncology April 24, 2025

VJOncology – The video journal of oncology

The Video Journal of Oncology (VJOncology) is an independent, global, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve the…

VJ Oncology April 24, 2025

Lenvatinib as a Key First-Line Therapy in RAI-Refractory DTC

Francis P. Worden, MD, discusses his key takeaways for other oncologists treating patients with radioidine-refractory differentiated thyroid cancer.

Targeted Oncology April 24, 2025

Related Articles